$UHT
UNIVERSAL HEALTH REALTY INCOME TRUST

2023 Q3 Form 10-Q Financial Statement

#000095017023039868 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $24.22M $23.81M
YoY Change 9.35% 7.37%
Cost Of Revenue $7.854M $8.250M
YoY Change 14.24% 18.09%
Gross Profit $16.37M $15.56M
YoY Change 7.16% 2.44%
Gross Profit Margin 67.58% 65.34%
Selling, General & Admin $1.332M $1.323M
YoY Change 2.7% 4.5%
% of Gross Profit 8.14% 8.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.012M $6.849M
YoY Change 5.32% 2.55%
% of Gross Profit 42.84% 44.03%
Operating Expenses $8.333M $8.172M
YoY Change 4.75% 3.03%
Operating Profit $8.025M $7.384M
YoY Change 9.62% 1.99%
Interest Expense -$4.164M -$3.908M
YoY Change 68.38% 92.04%
% of Operating Profit -51.89% -52.93%
Other Income/Expense, Net
YoY Change
Pretax Income $3.872M $3.476M
YoY Change -20.13% -33.38%
Income Tax
% Of Pretax Income
Net Earnings $3.872M $3.476M
YoY Change -20.13% -33.38%
Net Earnings / Revenue 15.98% 14.6%
Basic Earnings Per Share $0.28 $0.25
Diluted Earnings Per Share $0.28 $0.25
COMMON SHARES
Basic Shares Outstanding 13.82M 13.80M
Diluted Shares Outstanding 13.82M 13.81M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.359M $9.459M
YoY Change 3.17% 12.62%
Cash & Equivalents $8.359M $9.459M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $22.93M $23.78M
YoY Change 7.07% 14.0%
LONG-TERM ASSETS
Property, Plant & Equipment $461.0M $458.2M
YoY Change -0.07% -0.61%
Goodwill
YoY Change
Intangibles $9.650M $8.343M
YoY Change -2.88% -20.9%
Long-Term Investments $9.329M $9.296M
YoY Change -3.44% -4.29%
Other Assets $21.60M $20.20M
YoY Change -7.33% 12.65%
Total Long-Term Assets $585.0M $579.5M
YoY Change -0.5% -0.59%
TOTAL ASSETS
Total Short-Term Assets $22.93M $23.78M
Total Long-Term Assets $585.0M $579.5M
Total Assets $607.9M $603.3M
YoY Change -0.23% -0.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $25.09M $24.22M
YoY Change -1.29% 0.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.09M $24.22M
YoY Change -1.29% 0.58%
LONG-TERM LIABILITIES
Long-Term Debt $360.8M $351.1M
YoY Change 6.01% 4.81%
Other Long-Term Liabilities $11.67M $11.31M
YoY Change 17.71% 12.51%
Total Long-Term Liabilities $372.5M $362.5M
YoY Change 6.34% 5.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.09M $24.22M
Total Long-Term Liabilities $372.5M $362.5M
Total Liabilities $397.6M $386.7M
YoY Change 5.83% 4.74%
SHAREHOLDERS EQUITY
Retained Earnings $822.5M $818.6M
YoY Change 2.17% 2.3%
Common Stock $270.3M $270.1M
YoY Change 0.34% 0.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $210.3M $216.6M
YoY Change
Total Liabilities & Shareholders Equity $607.9M $603.3M
YoY Change -0.23% -0.08%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $3.872M $3.476M
YoY Change -20.13% -33.38%
Depreciation, Depletion And Amortization $7.012M $6.849M
YoY Change 5.32% 2.55%
Cash From Operating Activities $10.16M $12.25M
YoY Change 6.12% -7.42%
INVESTING ACTIVITIES
Capital Expenditures $11.03M $3.786M
YoY Change -301.44% -149.1%
Acquisitions
YoY Change
Other Investing Activities $73.00K $305.0K
YoY Change 135.48% 32.03%
Cash From Investing Activities -$10.96M -$3.481M
YoY Change 101.25% -53.46%
FINANCING ACTIVITIES
Cash Dividend Paid $9.900M $10.00M
YoY Change 1.02% 2.04%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -306.0K -7.434M
YoY Change -93.09% 19.21%
NET CHANGE
Cash From Operating Activities 10.16M 12.25M
Cash From Investing Activities -10.96M -3.481M
Cash From Financing Activities -306.0K -7.434M
Net Change In Cash -1.100M 1.339M
YoY Change 270.37% -378.96%
FREE CASH FLOW
Cash From Operating Activities $10.16M $12.25M
Capital Expenditures $11.03M $3.786M
Free Cash Flow -$867.0K $8.468M
YoY Change -105.76% -59.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000798783
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-9321
dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL HEALTH REALTY INCOME TRUST
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-6858580
dei Entity Address Address Line1
EntityAddressAddressLine1
UNIVERSAL CORPORATE CENTER
dei Entity Address Address Line2
EntityAddressAddressLine2
367 SOUTH GULPH ROAD
dei Entity Address City Or Town
EntityAddressCityOrTown
KING OF PRUSSIA
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19406-0958
dei City Area Code
CityAreaCode
610
dei Local Phone Number
LocalPhoneNumber
265-0688
dei Security12b Title
Security12bTitle
Shares of beneficial interest, $0.01 par value
dei Trading Symbol
TradingSymbol
UHT
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13822102
CY2023Q2 us-gaap Revenues
Revenues
23806000
CY2022Q2 us-gaap Revenues
Revenues
22171000
us-gaap Revenues
Revenues
47032000
us-gaap Revenues
Revenues
44346000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6849000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6679000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
13467000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
13388000
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8250000
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6986000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
15771000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
13853000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
16422000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
14931000
us-gaap Costs And Expenses
CostsAndExpenses
31863000
us-gaap Costs And Expenses
CostsAndExpenses
29731000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7384000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7240000
us-gaap Operating Income Loss
OperatingIncomeLoss
15169000
us-gaap Operating Income Loss
OperatingIncomeLoss
14615000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
268000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
345000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
639000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
597000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4176000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2367000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7873000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4589000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3476000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
5218000
us-gaap Net Income Loss
NetIncomeLoss
7935000
us-gaap Net Income Loss
NetIncomeLoss
10623000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13784000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13768000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13781000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13766000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13809000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13789000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13806000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13788000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3476000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
5218000
us-gaap Net Income Loss
NetIncomeLoss
7935000
us-gaap Net Income Loss
NetIncomeLoss
10623000
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
715000
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
2005000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1032000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
7689000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
715000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2005000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1032000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7689000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4191000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7223000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6903000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18312000
CY2023Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
642619000
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
641338000
CY2023Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
252365000
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
248772000
CY2023Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
390254000
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
392566000
CY2023Q2 us-gaap Land
Land
56631000
CY2022Q4 us-gaap Land
Land
56631000
CY2023Q2 us-gaap Real Estate Investments
RealEstateInvestments
446885000
CY2022Q4 us-gaap Real Estate Investments
RealEstateInvestments
449197000
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
83444000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
83603000
CY2023Q2 us-gaap Investments
Investments
530329000
CY2022Q4 us-gaap Investments
Investments
532800000
CY2023Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
9296000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
9282000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9459000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7614000
CY2023Q2 uht Lease And Other Receivables
LeaseAndOtherReceivables
5944000
CY2022Q4 uht Lease And Other Receivables
LeaseAndOtherReceivables
5388000
CY2023Q2 uht Lease Receivable Other
LeaseReceivableOther
8379000
CY2022Q4 uht Lease Receivable Other
LeaseReceivableOther
8445000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13100000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15400000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8343000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9447000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11010000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11457000
CY2023Q2 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
20203000
CY2022Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
23107000
CY2023Q2 us-gaap Assets
Assets
602963000
CY2022Q4 us-gaap Assets
Assets
607540000
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
311400000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
298100000
CY2023Q2 us-gaap Secured Debt
SecuredDebt
39741000
CY2022Q4 us-gaap Secured Debt
SecuredDebt
44725000
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
335000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
373000
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12531000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12873000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
11010000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11457000
CY2023Q2 uht Tenant Reserves Deposits And Deferred And Prepaid Rents
TenantReservesDepositsAndDeferredAndPrepaidRents
11311000
CY2022Q4 uht Tenant Reserves Deposits And Deferred And Prepaid Rents
TenantReservesDepositsAndDeferredAndPrepaidRents
10911000
CY2023Q2 us-gaap Liabilities
Liabilities
386328000
CY2022Q4 us-gaap Liabilities
Liabilities
378439000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13822027
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13822027
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13803335
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13803335
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
138000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
138000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
269923000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
269472000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
818596000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
810661000
CY2023Q2 us-gaap Cumulative Dividends
CumulativeDividends
883001000
CY2022Q4 us-gaap Cumulative Dividends
CumulativeDividends
863181000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10979000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12011000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
216635000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
229101000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
602963000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
607540000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
229101000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
376000
uht Dividends Per Share
DividendsPerShare
1.435
us-gaap Dividends
Dividends
19820000
us-gaap Net Income Loss
NetIncomeLoss
7935000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1032000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
6903000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
216635000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
222170000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
188000
CY2023Q2 uht Dividends Per Share
DividendsPerShare
0.72
CY2023Q2 us-gaap Dividends
Dividends
9951000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3476000
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
715000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4191000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
216635000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
235327000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
93000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
431000
uht Dividends Per Share
DividendsPerShare
1.415
us-gaap Dividends
Dividends
19517000
us-gaap Net Income Loss
NetIncomeLoss
10623000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
7689000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
18312000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
234646000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
236974000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
39000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
208000
CY2022Q2 uht Dividends Per Share
DividendsPerShare
0.71
CY2022Q2 us-gaap Dividends
Dividends
9798000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
5218000
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
2005000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7223000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
234646000
us-gaap Profit Loss
ProfitLoss
7935000
us-gaap Profit Loss
ProfitLoss
10623000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13467000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13388000
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-73000
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-72000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-24000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-25000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
347000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
359000
us-gaap Share Based Compensation
ShareBasedCompensation
376000
us-gaap Share Based Compensation
ShareBasedCompensation
431000
us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
490000
us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
713000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-618000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
273000
uht Increase Decrease In Tenant Reserves Deposits Deferred And Prepaid Rents
IncreaseDecreaseInTenantReservesDepositsDeferredAndPrepaidRents
-241000
uht Increase Decrease In Tenant Reserves Deposits Deferred And Prepaid Rents
IncreaseDecreaseInTenantReservesDepositsDeferredAndPrepaidRents
-275000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
38000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
23000
uht Increase Decrease In Leasing Costs
IncreaseDecreaseInLeasingCosts
604000
uht Increase Decrease In Leasing Costs
IncreaseDecreaseInLeasingCosts
770000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2285000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1744000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22322000
CY2022Q2 uht Annual Advisory Fees As Percentage Of Average Invested Real Estate Assets
AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets
0.0070
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24940000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3869000
uht Cash Distributions In Excess Of Income From Limited Liability Companies
CashDistributionsInExcessOfIncomeFromLimitedLiabilityCompanies
369000
uht Cash Distributions In Excess Of Income From Limited Liability Companies
CashDistributionsInExcessOfIncomeFromLimitedLiabilityCompanies
391000
us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
3500000
us-gaap Real Estate Period Increase Decrease
RealEstatePeriodIncreaseDecrease
-8789000
us-gaap Real Estate Period Increase Decrease
RealEstatePeriodIncreaseDecrease
-11223000
uht Payments For Deposit On Real Estate Assets
PaymentsForDepositOnRealEstateAssets
100000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13620000
uht Payments To Asset Exchange Transaction
PaymentsToAssetExchangeTransaction
-1346000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8889000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25798000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
13300000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
12400000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
4995000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
6170000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
132000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
26000
us-gaap Payments Of Dividends
PaymentsOfDividends
19837000
us-gaap Payments Of Dividends
PaymentsOfDividends
19545000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
76000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
94000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11588000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13247000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1845000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14105000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7614000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22504000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9459000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8399000
us-gaap Interest Paid Net
InterestPaidNet
7736000
us-gaap Interest Paid Net
InterestPaidNet
4333000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1808000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1709000
uht Number Of Bed Facility
NumberOfBedFacility
100
CY2023Q2 uht Annual Advisory Fees As Percentage Of Average Invested Real Estate Assets
AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets
0.0070
CY2023Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
10000000
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2022Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
9800000
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.71
us-gaap Payments Of Dividends
PaymentsOfDividends
19800000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.435
us-gaap Payments Of Dividends
PaymentsOfDividends
19500000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.415
us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
0
uht Number Of Businesses Disposed
NumberOfBusinessesDisposed
0
uht Number Of Businesses Disposed
NumberOfBusinessesDisposed
0
uht Number Of Properties
NumberOfProperties
2
CY2023Q2 uht Operating Expenses Excluding Depreciation And Amortization Expense
OperatingExpensesExcludingDepreciationAndAmortizationExpense
202000
CY2022Q2 uht Operating Expenses Excluding Depreciation And Amortization Expense
OperatingExpensesExcludingDepreciationAndAmortizationExpense
197000
uht Operating Expenses Excluding Depreciation And Amortization Expense
OperatingExpensesExcludingDepreciationAndAmortizationExpense
389000
uht Operating Expenses Excluding Depreciation And Amortization Expense
OperatingExpensesExcludingDepreciationAndAmortizationExpense
373000
uht Number Of Ground Leases For Land
NumberOfGroundLeasesForLand
15
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11000000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
11000000
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
311400000
CY2023Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3100000
CY2023Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
60500000
CY2023Q2 us-gaap Compensating Balance Amount
CompensatingBalanceAmount
0
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
298100000
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3100000
CY2022Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
73800000
CY2023Q2 uht Debt Instrument Covenant Tangible Net Worth
DebtInstrumentCovenantTangibleNetWorth
125000000
CY2023Q2 uht Tangible Net Worth
TangibleNetWorth
208292000
CY2022Q4 uht Tangible Net Worth
TangibleNetWorth
219654000
CY2023Q2 uht Leverage Ratio
LeverageRatio
0.439
CY2022Q4 uht Leverage Ratio
LeverageRatio
0.429
CY2023Q2 uht Secured Leverage Ratio
SecuredLeverageRatio
0.05
CY2022Q4 uht Secured Leverage Ratio
SecuredLeverageRatio
0.056
CY2023Q2 uht Unencumbered Leverage Ratio
UnencumberedLeverageRatio
0.434
CY2022Q4 uht Unencumbered Leverage Ratio
UnencumberedLeverageRatio
0.418
CY2023Q2 uht Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
0.036
CY2022Q4 uht Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
0.043
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-039868-index-headers.html Edgar Link pending
0000950170-23-039868-index.html Edgar Link pending
0000950170-23-039868.txt Edgar Link pending
0000950170-23-039868-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uht-20230630.htm Edgar Link pending
uht-20230630.xsd Edgar Link pending
uht-ex31_1.htm Edgar Link pending
uht-ex31_2.htm Edgar Link pending
uht-ex32_1.htm Edgar Link pending
uht-ex32_2.htm Edgar Link pending
uht-20230630_def.xml Edgar Link unprocessable
uht-20230630_lab.xml Edgar Link unprocessable
uht-20230630_pre.xml Edgar Link unprocessable
uht-20230630_htm.xml Edgar Link completed
uht-20230630_cal.xml Edgar Link unprocessable